New York, NY (July 12, 2013) The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, committing more than $680,000 to help address a critical shortage of funding for pediatric cancer research. The Sohn Conference Foundation, dedicated to curing pediatric cancers, announced last year that it was granting $1.5 million to the Damon Runyon Cancer Research Foundation, the leading charity supporting innovative young cancer researchers, to establish the award. It provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers. Each recipient receives a three-year award ($186,000 for physician-scientists, $156,000 for basic scientists). Since 2012, this award has supported seven innovative pediatric cancer researchers.
July 2013 Damon Runyon-Sohn Fellows
Kenneth Chen, MD, with his sponsor James Amatruda, MD, PhD, at the University of Texas Southwestern Medical Center, Dallas, Texas, studies Wilms tumor, a pediatric kidney cancer that is the fourth most common childhood cancer. Wilms tumor is treated with a combination of surgery, chemotherapy, and radiation; although outcomes have dramatically improved over the decades, they remain poor for children with high-risk disease. His preliminary research has identified a subset of Wilms tumors with dysregulated expression of microRNAs, a type of short noncoding RNA that regulates protein production. He will study how this dysregulation causes cancer in children and aims to use this information to develop a novel therapeutic strategy for these tumors.
Haihua Scott Chu, PhD, with his sponsor Scott A. Armstrong, MD, PhD, at Memorial-Sloan Kettering Cancer Center, New York, New York, focuses on a promising new class of therapy that inhibits epigene
|Contact: Yung S. Lie, Ph.D.|
Damon Runyon Cancer Research Foundation